Претраживање
Приказ резултата 41-50 од 261
Haemodynamic effects of no and vitamin C supplementation in SHR with acute renal failure
(Lippincott Williams & Wilkins, Philadelphia, 2006)
Resveratrol reduces blood pressure and systolic volume in SH rats
(Lippincott Williams & Wilkins, Philadelphia, 2008)
P1002: Anti-fibrotic activity of BMP2 in bone marrow-derived mesenchymal stromal cells of myeloproliferative neoplasms
(Wolters Kluwer Health, Inc., 2022)
Background: Myeloproliferative neoplasms (MPN) are clonal hematopoietic disorders that include polycythemia vera (PV), essential thrombocythemia (ET), and primary myelofibrosis (PMF). Bone marrow fibrosis (BMF) is a shared ...
Analyses of risk factors predicting the thrombotic complications in long-term follow up of 207 patients with essential thrombocythemia
(Ferrata Storti Foundation, Pavia, 2012)
Reaktivne vrste kiseonika u patofiziologiji bubrežnih oboljenja
(Beograd: Srpsko biološko društvo, 2022)
Uvod. Reaktivne vrste kiseonika (RVK), važni signalni molekuli, u uslovima prekomerne produkcije dovode do poremećaja funkcije i strukture organa i tkiva, uključujući bubreg. RVK doprinose dijabetičnim nefropatijama, ...
Hypoxia inducible genes, erythropoietin and vascular endothelial growth factor expression in renal cell carcinoma
(Ferrata Storti Foundation, Pavia, 2013)
Oxidative stress in myeloproliferative neoplasms
(Ferrata Storti Foundation, Pavia, 2014)
Proinflammatory cytokine il-6 stimulation of angiogenic factors and DNA replication is blocked by jak-stat pathway inhibition in myeloproliferative neoplasms
(Ferrata Storti Foundation, Pavia, 2017)
A prognostic model to predict thrombosis in essential thrombocythemia
(Ferrata Storti Foundation, Pavia, 2014)